CIK 1892770
Knott David M Jr
Institutional 13F holdings & portfolio
Holdings
87
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–50 of 87
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| CLMT | Calumet, Inc. | 2.2M | $1M+ | SH |
| APO | Apollo Global Management, Inc. | 225K | $1M+ | SH |
| GOOG | Alphabet Inc-Cl C | 91K | $1M+ | SH |
| SNDX | Syndax Pharmaceutical, Inc. | 415K | $1M+ | SH |
| XERS | Xeris Biopharma Holdings, Inc. | 970K | $1M+ | SH |
| TVTX | Travere Therapeutics, Inc. | 186K | $1M+ | SH |
| BBIO | Bridgebio Pharma, Inc. | 85K | $1M+ | SH |
| PTGX | Protagonist Therapeutics, Inc | 73K | $1M+ | SH |
| JPM | JPMorgan Chase & Co. | 19K | $1M+ | SH |
| JAAA | Janus Henderson AAA CLO ETF | 94K | $1M+ | SH |
| VRDN | Viridian Therapeutics, Inc. | 145K | $1M+ | SH |
| CPRX | Catalyst Pharmaceuticals, Inc. | 189K | $1M+ | SH |
| COGT | Cogent Biosciences Inc. | 102K | $1M+ | SH |
| RCUS | Arcus Biosciences, Inc. | 121K | $1M+ | SH |
| ALKS | Alkermes PLC | 95K | $1M+ | SH |
| DCGO | DocGo, Inc. | 2.7M | $1M+ | SH |
| HELP | Cybin Inc | 285K | $1M+ | SH |
| CYTK | Cytokinetics, Incorporated | 34K | $1M+ | SH |
| ATRC | AtriCure, Inc. | 51K | $1M+ | SH |
| AB | AllianceBernstein Holding L.P. | 48K | $1M+ | SH |
| ACLX | Arcellx Inc | 26K | $1M+ | SH |
| XBI | SPDR S&P Biotech ETF | 13K | $1M+ | SH |
| TECX | Tectonic Therapeutic, Inc. | 74K | $1M+ | SH |
| WVE | Wave Life Science Ltd. | 90K | $1M+ | SH |
| TGTX | TG Therapeutics, Inc. | 45K | $1M+ | SH |
| VERA | Vera Therapeutics, Inc. | 26K | $1M+ | SH |
| CLOZ | The Panagram BBB-B CLO ETF | 48K | $1M+ | SH |
| BHVN | Biohaven LTD | 111K | $1M+ | SH |
| JNJ | Johnson & Johnson | 6K | $1M+ | SH |
| BMY | Bristol-Myers Squibb Company | 22K | $1M+ | SH |
| MDGL | Madrigal Pharmaaceuticals, Inc. | 2K | $1M+ | SH |
| ADMA | ADMA Biologics, Inc. | 60K | $1M+ | SH |
| BIIB | Biogen Inc. | 6K | $1M+ | SH |
| OBIO | Orchestra Biomed Holdings, Inc. | 250K | $1M+ | SH |
| IBB | iShares Biotechnology ETF | 6K | $500K+ | SH |
| SLDB | Solid Bioscience Inc. | 162K | $500K+ | SH |
| LENZ | LENZ Therapeutics, Inc. | 54K | $500K+ | SH |
| PFE | Pfizer Inc. | 32K | $500K+ | SH |
| RZLT | Rezolute, Inc. | 340K | $500K+ | SH |
| MSFT | Microsoft Corporation | 2K | $500K+ | SH |
| AAPL | Apple Inc. | 2K | $500K+ | SH |
| EOLS | Evolus, Inc. | 99K | $500K+ | SH |
| NKTR | Nektar Therapeutics | 16K | $500K+ | SH |
| IBM | International Business Machines | 2K | $500K+ | SH |
| SRRK | Scholar Rock Holding Corporation | 14K | $500K+ | SH |
| PTHS | Pelthos Therapeutics, Inc. | 19K | $500K+ | SH |
| CNQ | Canadian Natural Resources Limited | 17K | $500K+ | SH |
| CNTB | Connect Biopharma Holdings Limited | 200K | $500K+ | SH |
| XENE | Xenon Pharmaceuticals Inc. | 11K | $100K–$500K | SH |
| AGIO | Agios Pharmaceutical, Inc. | 18K | $100K–$500K | SH |